Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,6-diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3s,4r)-
2. 3-((3s,4r)-3-methyl-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile
3. Jte-052
1. 1263774-59-9
2. Jte-052
3. Jte-052a
4. Corectim
5. Leo 124249a
6. Leo 124249
7. Leo-124249a
8. Leo-124249
9. Delgocitinib [usan]
10. 9l0q8kk220
11. 3-[(3s,4r)-3-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile
12. 3-((3s,4r)-3-methyl-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile
13. 3-[(3s,4r)-3-methyl-7-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile
14. Delgocitinibum
15. Corectim (tn)
16. 3-((3s,4r)-3-methyl-6-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl)-3-oxopropanenitrile
17. 3-[(3s,4r)-3-methyl-6-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile
18. Ent-60
19. Delgocitinib (jan/usan)
20. Delgocitinib [inn]
21. Delgocitinib [jan]
22. Delgocitinib [who-dd]
23. Unii-9l0q8kk220
24. Gtpl9619
25. Jte052
26. Chembl4297507
27. Schembl12547007
28. Chebi:167600
29. Dtxsid401336933
30. Ex-a5577
31. Bdbm50545650
32. At24880
33. Leo-124249;jte-052
34. Bd178539
35. Hy-109053
36. Cs-0031558
37. D11046
38. A936874
39. 1,6-diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-.beta.-oxo-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3s,4r)-
40. 1,6-diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3s,4r)-
41. Fhx
| Molecular Weight | 310.35 g/mol |
|---|---|
| Molecular Formula | C16H18N6O |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 310.15420922 g/mol |
| Monoisotopic Mass | 310.15420922 g/mol |
| Topological Polar Surface Area | 88.9 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of dermatitis and eczema
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Delgocitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Delgocitinib, including repackagers and relabelers. The FDA regulates Delgocitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Delgocitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Delgocitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Delgocitinib supplier is an individual or a company that provides Delgocitinib active pharmaceutical ingredient (API) or Delgocitinib finished formulations upon request. The Delgocitinib suppliers may include Delgocitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Delgocitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Delgocitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Delgocitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Delgocitinib GMP manufacturer or Delgocitinib GMP API supplier for your needs.
A Delgocitinib CoA (Certificate of Analysis) is a formal document that attests to Delgocitinib's compliance with Delgocitinib specifications and serves as a tool for batch-level quality control.
Delgocitinib CoA mostly includes findings from lab analyses of a specific batch. For each Delgocitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Delgocitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Delgocitinib EP), Delgocitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Delgocitinib USP).
LOOKING FOR A SUPPLIER?
